Regulators in the U.S. and China have granted Xellsmart permission to start clinical testing of its experimental stem cell therapy in people with multiple system atrophy-Parkinsonian type (MSA-P). This is the fourth clinical trial program for Xellsmart’s stem cell therapy platform to have received regulatory clearance from both the…
News
Japan’s Ministry of Health, Labour and Welfare has granted conditional approval to Amchepry, Sumitomo Pharma’s stem cell-derived therapy designed to replace dopamine-producing nerve cells, for people with Parkinson’s disease who do not respond adequately to existing treatments such as levodopa. The approval was based on results from a …
A fully implanted brain device can identify when people with Parkinson’s disease are walking during their everyday lives, according to a new study from the University of California, San Francisco (UCSF). By recording neural activity from movement-related brain regions while patients went about their normal routines at home, researchers…
Impaired cellular energy may interfere with how dopamine — the key chemical messenger that is in short supply in Parkinson’s disease — is packaged and handled inside nerve cells, a new study has found. According to the researchers, such disruptions, and a resulting energy shortage, may promote the formation…
The Silvi Foundation has officially launched as a nonprofit organization dedicated to advancing research into Parkinson’s disease and other neurodegenerative conditions. As its first initiative, the newly established foundation has awarded a $100,000 grant to the Institute for Neurodegenerative Diseases (IND) to support research on blood-based biomarkers…
The Parkinson’s Foundation has released its new national strategy dedicated to improving care for people with Parkinson’s disease by focusing on practical, patient-centered solutions that the nonprofit says will address the real challenges now facing the U.S. community. The new strategy, dubbed Parkinson’s Care and Innovation: A…
Quitting smoking was linked to a greater risk of Parkinson’s disease compared with continuing to smoke, but it was also associated with a smaller risk of death — especially among those who quit and remained smoke-free — in a large-scale study conducted in South Korea. These new data come…
Despite strong evidence linking paraquat to Parkinson’s disease, the herbicide is still legal in the U.S., although some states are moving to restrict or ban it to protect public health. Advocates, including the American Parkinson’s Disease Association (APDA), are also urging action to align federal policy with more…
A protein found in a common liverwort plant could be engineered to clear the toxic protein clumps associated with Parkinson’s disease, according to a new study. Researchers discovered that this plant-based protein acts as a “molecular bridge,” successfully linking harmful alpha-synuclein to a human cell’s internal recycling…
The first patient has been dosed in a U.S. clinical trial testing Iregene Therapeutics’ off-the-shelf, or ready-to-use, cell therapy NouvNeu001 for Parkinson’s disease. The therapy was delivered to both sides of the putamen — a brain region deeply affected in Parkinson’s and central to movement control — in…
Recent Posts
- The invisible support a Parkinson’s caregiver provides
- US, China regulators OK trials of stem cell therapy in MSA-P
- When caregiver stress hits, I remember to have ‘just a little patience’
- Japan grants conditional approval to Amchepry cell therapy for Parkinson’s
- Good design for those of us with mobility issues is good design for all